Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.
Saved in:
| Title: | Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study. |
|---|---|
| Authors: | Mauritz AJW; Department of Radiation Oncology Maastro, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands. Electronic address: fleur.mauritz@maastro.nl., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Simons JM; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands., Verloop J; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., van Dalen T; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands., Elkhuizen PHM; Department of Radiation Oncology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands., Scholten A; Department of Radiation Oncology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands., Houben RMA; Department of Radiation Oncology Maastro, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, Utrecht, Netherlands., Linn SC; Department of Medical Oncology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands; Department of Pathology Cancer, University Medical Centre Utrecht, Utrecht, Netherlands., Pijnappel RM; Department of Radiology, University Medical Centre Utrecht, Utrecht, Netherlands., Poortmans PMP; Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium., Strobbe LJA; Department of Surgery, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, Netherlands; Early Detection Centre, Netherlands Cancer Institute, Amsterdam, Netherlands., Wesseling J; Department of Pathology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands., Voogd AC; Department of Epidemiology, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands., Boersma LJ; Department of Radiation Oncology Maastro, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands. |
| Source: | The Lancet. Oncology [Lancet Oncol] 2026 Jul; Vol. 27 (7), pp. 808-816. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42372742 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Mauritz+AJW%22">Mauritz AJW</searchLink>; Department of Radiation Oncology Maastro, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands. Electronic address: fleur.mauritz@maastro.nl.<br /><searchLink fieldCode="AU" term="%22de+Munck+L%22">de Munck L</searchLink>; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Simons+JM%22">Simons JM</searchLink>; Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Verloop+J%22">Verloop J</searchLink>; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Dalen+T%22">van Dalen T</searchLink>; Department of Surgery, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Elkhuizen+PHM%22">Elkhuizen PHM</searchLink>; Department of Radiation Oncology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Scholten+A%22">Scholten A</searchLink>; Department of Radiation Oncology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Houben+RMA%22">Houben RMA</searchLink>; Department of Radiation Oncology Maastro, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Leeuwen-Stok+AE%22">van Leeuwen-Stok AE</searchLink>; Dutch Breast Cancer Research Group, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Linn+SC%22">Linn SC</searchLink>; Department of Medical Oncology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands; Department of Pathology Cancer, University Medical Centre Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Pijnappel+RM%22">Pijnappel RM</searchLink>; Department of Radiology, University Medical Centre Utrecht, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Poortmans+PMP%22">Poortmans PMP</searchLink>; Department of Radiation Oncology, Iridium Netwerk, Wilrijk-Antwerp, Belgium; Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk-Antwerp, Belgium.<br /><searchLink fieldCode="AU" term="%22Strobbe+LJA%22">Strobbe LJA</searchLink>; Department of Surgery, Canisius Wilhelmina Hospital Nijmegen, Nijmegen, Netherlands; Early Detection Centre, Netherlands Cancer Institute, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Wesseling+J%22">Wesseling J</searchLink>; Department of Pathology, Antoni van Leeuwenhoek Ziekenhuis, Amsterdam, Netherlands; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Pathology, Leiden University Medical Centre, Leiden, Netherlands.<br /><searchLink fieldCode="AU" term="%22Voogd+AC%22">Voogd AC</searchLink>; Department of Epidemiology, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, Netherlands.<br /><searchLink fieldCode="AU" term="%22Boersma+LJ%22">Boersma LJ</searchLink>; Department of Radiation Oncology Maastro, GROW Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2026 Jul; Vol. 27 (7), pp. 808-816. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Observational Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42372742 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(26)00216-0 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 808 Titles: – TitleFull: Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Mauritz AJW – PersonEntity: Name: NameFull: de Munck L – PersonEntity: Name: NameFull: Simons JM – PersonEntity: Name: NameFull: Verloop J – PersonEntity: Name: NameFull: van Dalen T – PersonEntity: Name: NameFull: Elkhuizen PHM – PersonEntity: Name: NameFull: Scholten A – PersonEntity: Name: NameFull: Houben RMA – PersonEntity: Name: NameFull: van Leeuwen-Stok AE – PersonEntity: Name: NameFull: Linn SC – PersonEntity: Name: NameFull: Pijnappel RM – PersonEntity: Name: NameFull: Poortmans PMP – PersonEntity: Name: NameFull: Strobbe LJA – PersonEntity: Name: NameFull: Wesseling J – PersonEntity: Name: NameFull: Voogd AC – PersonEntity: Name: NameFull: Boersma LJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2026 Jul Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1474-5488 Numbering: – Type: volume Value: 27 – Type: issue Value: 7 Titles: – TitleFull: The Lancet. Oncology Type: main |
| ResultId | 1 |
